Non-Inferiority of Once-Daily Cobicistat-Boosted Darunavir Versus Ritonavir-Boosted Darunavir in Hiv-1-infected Adult Patients: An Adjusted Comparative Analysis of Pooled Phase 3 Data

Value Health. 2014 Nov;17(7):A664. doi: 10.1016/j.jval.2014.08.2442. Epub 2014 Oct 26.

Authors

S Van Sanden¹, P Thilakarathne¹, M Opsomer¹, J Mrus², S Vanveggel¹, E Lathouwers¹, I Adriaenssen³

Affiliations

¹ Janssen Infectious Diseases BVBA, Beerse, Belgium.
² Janssen Global Services, Titusville, NJ, USA.
³ Janssen Global Services, Beerse, Belgium.

PMID: 27202422
DOI: 10.1016/j.jval.2014.08.2442

No abstract available